Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
10.84
-0.38 (-3.39%)
Jul 11, 2025, 4:00 PM - Market closed
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $144.91 million as of July 11, 2025. Its market cap has decreased by -26.85% in one year.
Market Cap
144.91M
Enterprise Value
142.16M
1-Year Change
-26.85%
Ranking
Category
Stock Price
$10.84
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $144.91M, an increase of 110.97%. That is a compound annual growth rate of 16.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 11, 2025 | 144.91M | -1.83% |
Dec 31, 2024 | 147.61M | 9.21% |
Dec 29, 2023 | 135.16M | -30.79% |
Dec 30, 2022 | 195.29M | -38.84% |
Dec 31, 2021 | 319.29M | -31.08% |
Dec 31, 2020 | 463.30M | 574.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 711.91B |
Johnson & Johnson | 377.51B |
AbbVie | 339.94B |
Novo Nordisk | 305.41B |
UnitedHealth Group | 275.86B |
Novartis AG | 236.71B |
Abbott Laboratories | 229.69B |
AstraZeneca | 218.74B |